Trump Imposes 35% Tariff on Canada Over Fentanyl, Trade Disputes

U.S. President Donald Trump announced a 35% trade tariff on Canadian imports starting August 1, citing the flow of Fentanyl and alleged unfair trade practices as key reasons. In a letter to Canadian Prime Minister Mark Carney, Trump emphasized that the new tariff will be separate from previously announced sectoral tariffs targeting automobiles and key commodities.

Trump accused Canada of contributing to the illegal Fentanyl crisis in the U.S. and claimed the Canadian government imposes excessively high tariffs on American products, particularly pointing to a 400% duty on U.S. dairy exports. He argued these issues not only create trade imbalances but also pose national security risks.

Warning against retaliation, Trump urged Canadian firms to shift manufacturing to the U.S., promising swift regulatory approvals and exemption from tariffs for companies that relocate operations. He also stated he would consider easing the new duties if Canada takes action to curb the Fentanyl trade into the U.S.

This move follows a series of tariff announcements by Trump targeting key U.S. trade partners. Earlier this week, the administration unveiled 25% tariffs on imports from South Korea and Japan. These measures are part of Trump’s broader "Liberation Day" economic agenda aimed at revamping global trade relations and encouraging domestic manufacturing.

While originally scheduled to begin on July 9, Trump postponed the tariff implementation to August 1 to allow countries more time to negotiate new trade deals with Washington. The aggressive trade stance has drawn criticism internationally, but Trump maintains it’s a necessary step to protect American workers and industries from what he deems unfair foreign policies.

The escalating trade tensions signal a tougher U.S. stance as Trump pushes for stronger domestic production and tighter control over drug-related imports.